Page 9 - Discover Top Biotechnology Partners From Poland - Business Catalogue

Polish Biotechnology Sector Polish Biotechnology Sector

COMPANY NAME: Ardigen COMPANY NAME: Auxilius Pharma

WEBSITE : https://www.ardigen.com WEBSITE : https://www.auxiliuspharma.com
YEAR OF ESTABLISHMENT: 2015 YEAR OF ESTABLISHMENT: 2019
NUMBER OF EMPLOYEES: 230 NUMBER OF EMPLOYEES: 8
CERTIFICATIONS: ISO 27001, Great Place to Work CERTIFICATIONS: Auxilius Pharma has implemented Quality Management System to be fully
compliant with GCP, GMP and GLP standards.
PRODUCTS: Artificial Intelligence and Bioinformatics services for Drug Development PRODUCTS: Auxilius Pharma is developing a new once-daily, first line agent for Chronic Stable
and Precision Medicine, AI CRO in the fields of Target ID, Hit to Lead, Angina Pectors, a diseaseaffecting 3-4% of the population. The product has been
Phenotypic Screening, Small Molecules, Neoantigens, TCRs, Antibodies, in use in the EU but not yet approved in the US. Auxilius Pharma has
Microbiome, Multiomics, Single Cell, Computer Vision, GPT Models, reformulated it into a once daily to add value to patients by improving the quality
Machine Learning, Data Engineering. of control of the underlying condition.
FORM OF COOPERATION: Trade and distribution FORM OF COOPERATION: Investment

Our mission is to to improve the lives of our patients by
offering them access to effective and verified
Ardigen, AI CRO company, enables AI transformation for
pharmaceutical treatments in convenient dosage form. We
biotech and pharmaceutical companies to leverage the full
are developing a unique portfolio of value-added
potential of data. The company delivers value at the
reformulated product candidates by utilizing expertise and
intersection of biology and computational methods to
technological advancements in drug formulation and
increase the likelihood of success and accelerate the drug
manufacturing. Our development approach makes use of
discovery process. With our platforms based on advanced
the 505(b)(2) regulatory pathway in the US. This pathway
algorithms and state-of-the-art technology, we help
has been created for pharmaceutics for which the safety
researchers to get scientific insights from a large amount of
and efficacy have previously been demonstrated. This
data, leading to new discoveries and breakthroughs in fields
targeted approach can considerably cut the amount of
such as personalized medicine and drug development.
clinical work necessary to get a product to market, shorten
the development cycle, and lower costs and risk.